SERIAL MEASUREMENT OF CA 125 IN PATIENTS WITH PRIMARY-CARCINOMA OF THE FALLOPIAN-TUBE

被引：28

作者：

TOKUNAGA, T ^{[1
]}

MIYAZAKI, K ^{[1
]}

MATSUYAMA, S ^{[1
]}

OKAMURA, H ^{[1
]}

机构：

[1] KUMAMOTO UNIV,SCH MED,KUMAMOTO 860,JAPAN

来源：

GYNECOLOGIC ONCOLOGY | 1990年 / 36卷 / 03期

关键词：

D O I：

10.1016/0090-8258(90)90137-A

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Serial assay of serum CA 125 was carried out in five patients with advanced primary carcinoma of the fallopian tube. Pretreatmental levels of these patients were elevated, ranging from 145 to 535 U/ml (305 ± 140.1, mean ± SD). All patients showed rapid decreases in response to treatment; however, reelevations were noted in two patients concomitant with recurrence. In the remaining three patients, who are alive with no evidence of recurrence at 52,29, and 21 months, serum CA 125 levels remained below 5 U/ml after remission. These results suggest that CA 125 is useful in monitoring patients with primary carcinoma of the fallopian tube. © 1990.

引用

收藏

页码：335 / 337

页数：3

相关论文

共 9 条

[1] A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER [J].

BAST, RC ;

KLUG, TL ;

STJOHN, E ;

JENISON, E ;

NILOFF, JM ;

LAZARUS, H ;

BERKOWITZ, RS ;

LEAVITT, T ;

GRIFFITHS, CT ;

PARKER, L ;

ZURAWSKI, VR ;

KNAPP, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) :883-887

[2] REACTIVITY OF A MONOCLONAL-ANTIBODY WITH HUMAN OVARIAN-CARCINOMA [J].

BAST, RC ;

FEENEY, M ;

LAZARUS, H ;

NADLER, LM ;

COLVIN, RB ;

KNAPP, RC .

JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1331-1337

[3] CA-125 SERUM LEVELS CORRELATED WITH 2ND-LOOK OPERATIONS AMONG OVARIAN-CANCER PATIENTS [J].

BEREK, JS ;

KNAPP, RC ;

MALKASIAN, GD ;

LAVIN, PT ;

WHITNEY, C ;

NILOFF, JM ;

BAST, RC .

OBSTETRICS AND GYNECOLOGY, 1986, 67 (05) :685-689

[4] OVARIAN-CANCER ANTIGEN CA125 - A PROSPECTIVE CLINICAL-ASSESSMENT OF ITS ROLE AS A TUMOR-MARKER [J].

CANNEY, PA ;

MOORE, M ;

WILKINSON, PM ;

JAMES, RD .

BRITISH JOURNAL OF CANCER, 1984, 50 (06) :765-769

[5] THE VALUE OF CA-125 SERUM ASSAY IN THE MANAGEMENT OF OVARIAN-CANCER [J].

LAMBERT, J .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (03) :193-195

[6] LEVELS OF CA 125 IN PATIENTS WITH RECURRENT CARCINOMA OF THE FALLOPIAN-TUBE - 2 CASE-HISTORIES [J].

LOOTSMAMIKLOSOVA, E ;

AALDERS, JG ;

WILLEMSE, PHB ;

DEBRUIJN, HWA .

EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1987, 24 (03) :231-235

[7] ELEVATION OF SERUM CA125 IN CARCINOMAS OF THE FALLOPIAN-TUBE, ENDOMETRIUM, AND ENDOCERVIX [J].

NILOFF, JM ;

KLUG, TL ;

SCHAETZL, E ;

ZURAWSKI, VR ;

KNAPP, RC ;

BAST, RC .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 148 (08) :1057-1058

[8] ADENOCARCINOMA OF THE UTERINE TUBE - POTENTIAL FOR LYMPH-NODE METASTASES [J].

TAMIMI, HK ;

FIGGE, DC .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1981, 141 (02) :132-137

[9]

Yoonessi M, 1979, Obstet Gynecol Surv, V34, P257, DOI 10.1097/00006254-197904000-00001